DEF: Sabra Health Care REIT Schedules 2026 Annual Meeting

Sabra Health Care REIT, Inc. has announced its 2026 Annual Meeting of Stockholders, set for June 17, 2026, to elect directors, ratify auditor appointment, and vote on executive compensation.

Summary

• Sabra Health Care REIT, Inc. is holding its 2026 Annual Meeting of Stockholders on June 17, 2026, at its headquarters in Tustin, California.
• Key agenda items include the election of seven directors, ratification of PricewaterhouseCoopers LLP as the independent auditor for fiscal year 2026, and an advisory vote on the compensation of named executive officers.
• The record date for stockholders entitled to vote is April 14, 2026.
• The company is utilizing internet availability for proxy materials to reduce costs and environmental impact.
• Voting can be done via internet, telephone, mail, or in person at the meeting.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing as moderately positive, highlighting strong TSR performance and robust corporate governance, while the routine nature of the meeting and standard proposals indicate expected operational continuity.

Positives

• The company is holding its annual meeting as scheduled, indicating operational continuity.
• A high percentage of votes (approximately 96.0%) supported the say-on-pay proposal in the previous year, suggesting stockholder confidence in executive compensation practices.
• The company has a robust corporate governance framework, including a highly independent board and fully independent committees.
• Sabra's total shareholder return (TSR) for 2025 was 17.02%, significantly outperforming the Nareit All Equity REITs Index TSR of -1.21%.

Risks

• The filing does not explicitly detail new or emerging risks, but standard risks associated with real estate investment trusts, such as market fluctuations, interest rate changes, and operational challenges for tenants, are implicitly present.
• The company's reliance on operators for environmental measures at triple-net leased properties means that implementation is managed by third parties, introducing a degree of indirect risk.

Future Outlook

The company entered 2026 with a robust investment pipeline and enhanced financial strength, driven by its focus on internal and external growth, portfolio enhancement, and balance sheet strengthening.

Management Comments

• The Compensation Committee continues to believe that the executive compensation program objective is to reward our executives for successfully creating long-term stockholder value by executing on our strategic plan, while at the same time holding executives accountable for performance and requiring forfeiture of compensation if they are not able to successfully execute our strategic plan and grow stockholder value.
• We believe that our executive compensation program is appropriately structured to accomplish these objectives.
• We believe that a diverse workforce is essential to our continued success, and we strive to maintain a fair, healthy and safe workplace, while creating a work environment that promotes diversity, equity and inclusion for our teammates.

Industry Context

StockSavvy.ai notes that Sabra's focus on diversifying its portfolio, with senior housing concentration at approximately 35.1% and skilled nursing under 50% of Annualized Cash NOI, aligns with broader industry trends of managing risk through diversification within the healthcare REIT sector.

Comparison to Industry Standards

• Sabra's 2025 Total Shareholder Return (TSR) of 17.02% significantly outperformed the Nareit All Equity REITs Index TSR of -1.21%.
• The company's Net Debt to Adjusted EBITDA ratio of 5.00x as of December 31, 2025, is a key metric for leverage assessment within the REIT industry.
• The executive compensation structure, with 65% of grant date value of annual equity awards being performance-based (TSR Units), aligns with industry practices aiming to link executive pay to long-term stockholder value creation.
• The peer group for compensation analysis includes a broad range of REITs such as CareTrust REIT, Inc., Community Healthcare Trust Incorporated, EPR Properties, and Medical Properties Trust, Inc., reflecting standard industry benchmarking practices.

Management Changes

Corporate Governance

Related Party Transactions

• Entered into a consulting agreement with Talya Nevo-Hacohen in March 2025 for transition assistance, providing an annual fee of $900,000 and continued medical benefits.
• The company has not participated in any other material transactions with related persons since the beginning of fiscal year 2025.

Stakeholder Impact

• Shareholders: The meeting addresses director elections, auditor ratification, and executive compensation, all of which directly impact shareholder value and governance.
• Employees: The company emphasizes attracting and retaining talent, investing in employee development, and promoting diversity, equity, and inclusion.
• Operators/Tenants: The company works with operators to encourage sustainability and health/safety practices, particularly in triple-net leased properties.

Next Steps

• Stockholders are encouraged to submit their proxy or voting instructions.
• The company will announce preliminary voting results at the Annual Meeting and disclose final results in a Form 8-K filing.
• Stockholder proposals for the 2027 Annual Meeting must be received by December 25, 2026.

Key Dates

Recommendation

This filing is a routine proxy statement for an annual meeting. While it highlights positive TSR performance and strong governance, it does not contain new strategic information or significant financial results that would warrant a change in investment recommendation. The company's performance and outlook appear stable and in line with expectations.

Keywords

Sabra Health Care REIT, Proxy Statement, Annual Meeting, DEF 14A, Director Election, Executive Compensation, Independent Auditor, Stockholder Vote